International Clinical Trial: Intratumoral Fusobacterium nucleatum Is Associated with Tumor Immune Microenvironment and High-Risk Pathological Features in Early Colorectal Cancer: A Retrospective Study

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120359) titled 'Intratumoral Fusobacterium nucleatum Is Associated with Tumor Immune Microenvironment and High-Risk Pathological Features in Early Colorectal Cancer: A Retrospective Study' on March 12.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The First Hospital of Nanchang

Condition: Early colorectal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-15

Target Sample Size: HGIN/T1 adenocarcinoma.:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313628

Published by HT Digital Content Services w...